Anthropic bankers prepare to raise IPO valuation to USD 1.5tln or above, according to FT
Newsquawk Staff ·
Anthropic bankers prepare to raise IPO valuation to USD 1.5tln or above, according to FT.
What it means
Bankers guiding an IPO valuation upward ahead of pricing follows a familiar sequence in hot listings: informal soundings, press leaks through the financial press to test demand, then a revised range or upsized deal. The leak itself is part of the process, and the sourcing attribution signals an early, non-binding stage rather than a filed range. In prior episodes of large private companies approaching the market at headline valuations well above their last funding round, the questions that have mattered are whether the cornerstones and anchor books materialise at that level and how much of the float is priced versus talked. AI-linked issuers have historically drawn deep demand at announcement, but aftermarket performance in that cohort has split sharply between revenue-generating names and those priced on capacity narratives. Worth watching is whether the figure survives contact with a formal filing, the size of the primary versus secondary component, and whether syndicate banks commit to a greenshoe consistent with the touted number.
Sources
- Fox's Gasparino, on Nvidia (NVDA), posts "The solution, unfortunately, is for shareholders to get screwed more in the short run before someone smart rights the old ship, which might make what we are seeing now a buying opportunity for $NVDA"
- UK's Ofcom has imposed a financial penalty against Meta (META)
- Daily US Equity Opening News - NVDA board considers CEO ouster after fresh affair allegations; Hon Hai Q3 net profit beat; CRWV slides on USD 4bln financing report; CTVA down on guidance cut; PFE & BX agree USD 1.5bln obesity co-funding
- Ukrainian President Zelensky posts that the SpaceX (SPCX) Starshield system speed limits are in effect at 161 kilometers per hour
- Alphabet's (GOOG) Google gets backing from a European court adviser on a USD 1.7bln antitrust fine
Related headlines
- Citrini's Jukan says that "One thing I’ve been able to confirm is that NVIDIA's (NVDA) Rubin has been delayed again. I’m told motherboard warpage caused the latest delay and that the HBM issue was resolved in October"2 hours ago
- US Commerce Department is finalising AI remote access rule, according to The Information7 hours ago
- US Senator Warren's office says the Trump administration must keep all documents and communications related to NVIDIA's (NVDA) exports of advanced AI chips to China7 hours ago
- Some NVIDIA (NVDA) directors favor CFO Kress as interim CEO, according to Semafor8 hours ago
- Top Democrats target Trump administration's Nvidia (NVDA)-China records, with Senators Warren and Coons asking for documents to be preserved, which is often the initial step before formal congressional investigations, according to WSJ8 hours ago
- South Korea President Lee says Samsung's (005930 KS) KRW 6.1tln investment in HBM chip packaging fab in South Korea's Asan will be followed by around KRW 40tln in advanced equipment investments9 hours ago
- Alleged Chinese spy in the NVIDIA (NVDA) scandal Alice Huang is reportedly in China and is living in Beijing with the knowledge of security officials, according to Bloomberg9 hours ago
- White House says it isn't intervening in NVIDIA (NVDA) board's decision, according to Washington Post10 hours ago
- US President Trump's administration is aware that NVIDIA's (NVDA) board of directors is preparing to oust Nvidia CEO Jensen Huang, very soon, according to CBS reporter Jennifer Jacobs11 hours ago
- CoreWeave (CRWV) is said to eye at USD 4bln from an investment-grade loan sale12 hours ago
- Strategy (MSTR) is to be removed from MSCI Global Investable Market Indexes following MSCI's implementation of a new non-operating company rule.12 hours ago
- NVIDIA (NVDA) is reportedly preparing to oust CEO Jensen Huang, according to WSJ12 hours ago
- NVIDIA (NVDA) CEO Huang is said to have had a relationship with an NVIDIA executive, according to NYT12 hours ago
- Pfizer (PFE) and Blackstone (BX) Life Sciences have entered into a strategic financing partnership, under which Blackstone will commit up to USD 1.50bln to support Pfizer’s berobenatide obesity programme through 2028, with Pfizer maintaining full operatio13 hours ago
- Newsquawk US Market Wrap - Stocks gain as CoreWeave earnings ease AI fears13 hours ago